These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 23604130)
1. Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment. Casazza A; Di Conza G; Wenes M; Finisguerra V; Deschoemaeker S; Mazzone M Oncogene; 2014 Apr; 33(14):1743-54. PubMed ID: 23604130 [TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming of the tumour microenvironment. Xing Y; Zhao S; Zhou BP; Mi J FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648 [TBL] [Abstract][Full Text] [Related]
3. Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation. Chargari C; Clemenson C; Martins I; Perfettini JL; Deutsch E Drug Resist Updat; 2013; 16(1-2):10-21. PubMed ID: 23434004 [TBL] [Abstract][Full Text] [Related]
4. Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed. Ganss R J Cell Mol Med; 2006; 10(4):857-65. PubMed ID: 17125590 [TBL] [Abstract][Full Text] [Related]
5. Hallmarks of cancer: interactions with the tumor stroma. Pietras K; Ostman A Exp Cell Res; 2010 May; 316(8):1324-31. PubMed ID: 20211171 [TBL] [Abstract][Full Text] [Related]
6. [Role of the stroma in the initiation and progression of tumors]. Baranyi M; Lippai M; Szatmári Z Orv Hetil; 2015 Nov; 156(45):1816-23. PubMed ID: 26522855 [TBL] [Abstract][Full Text] [Related]
8. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure. Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833 [TBL] [Abstract][Full Text] [Related]
9. Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression. Goto H; Nishioka Y Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286323 [TBL] [Abstract][Full Text] [Related]
10. Cancer as a changed tissue's way of life (when to treat, when to watch and when to think). Demicheli R; Quiton DF; Fornili M; Hrushesky WJ Future Oncol; 2016 Mar; 12(5):647-57. PubMed ID: 26880385 [TBL] [Abstract][Full Text] [Related]
11. Contribution of Tumor Endothelial Cells in Cancer Progression. Hida K; Maishi N; Annan DA; Hida Y Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087 [TBL] [Abstract][Full Text] [Related]
12. Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy. Zins K; Sioud M; Aharinejad S; Lucas T; Abraham D Methods Mol Biol; 2015; 1218():143-61. PubMed ID: 25319650 [TBL] [Abstract][Full Text] [Related]
13. Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response. Noman MZ; Messai Y; Carré T; Akalay I; Méron M; Janji B; Hasmim M; Chouaib S Crit Rev Immunol; 2011; 31(5):357-77. PubMed ID: 22142164 [TBL] [Abstract][Full Text] [Related]
14. Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics. Lin Q; Yun Z Cancer Biol Ther; 2010 Jun; 9(12):949-56. PubMed ID: 20581454 [TBL] [Abstract][Full Text] [Related]
16. Understanding the role of stromal fibroblasts in cancer progression. Tripathi M; Billet S; Bhowmick NA Cell Adh Migr; 2012; 6(3):231-5. PubMed ID: 22568983 [TBL] [Abstract][Full Text] [Related]
17. Engineering a Vascularized Hypoxic Tumor Model for Therapeutic Assessment. Ando Y; Oh JM; Zhao W; Tran M; Shen K Cells; 2021 Aug; 10(9):. PubMed ID: 34571851 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation. Collet G; Skrzypek K; Grillon C; Matejuk A; El Hafni-Rahbi B; Lamerant-Fayel N; Kieda C Vascul Pharmacol; 2012; 56(5-6):252-61. PubMed ID: 22446152 [TBL] [Abstract][Full Text] [Related]